Cargando…

The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer

BACKGROUND: Semaphorin 4D (Sema4D) belongs to the class IV semaphorins, and accumulating evidence has indicated that its elevated level may be one strategy by which tumors evade current anti-angiogenic therapies. The biological roles of Sema4D in colorectal cancer (CRC), however, remain largely unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Xiaojie, Qiu, Lijuan, Zhang, Lijuan, Xi, Juemin, Li, Duo, Huang, Xinwei, Zhao, Yujiao, Wang, Xiaodang, Sun, Qiangming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789851/ https://www.ncbi.nlm.nih.gov/pubmed/27022279 http://dx.doi.org/10.2147/OTT.S98906

Ejemplares similares

Regulatory sequence analysis of semaphorin 4D 5' non-coding region
por: Qiu, Lijuan, et al.
Publicado: (2019)

Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy
por: Huang, Xinwei, et al.
Publicado: (2016)

The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer
por: Jiang, Hongchao, et al.
Publicado: (2016)

Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways
por: Jiang, Hongchao, et al.
Publicado: (2021)

The polymorphisms of LCR, E6, and E7 of HPV-58 isolates in Yunnan, Southwest China
por: Xi, Juemin, et al.
Publicado: (2018)

Genetic variability and functional implication of the long control region in HPV-16 variants in Southwest China
por: Xi, Juemin, et al.
Publicado: (2017)

Dynamic Biomarkers of Response to Antiangiogenic Therapies in Colorectal Cancer: A Review
por: Rodriguez-Pascual, Jesus, et al.
Publicado: (2017)

Molecular Characterization and Viral Origin of the 2015 Dengue Outbreak in Xishuangbanna, Yunnan, China
por: Zhao, Yujiao, et al.
Publicado: (2016)

Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer
por: Wang, Zhen, et al.
Publicado: (2017)

Complete Genome Characterization of the 2017 Dengue Outbreak in Xishuangbanna, a Border City of China, Burma and Laos
por: Wen, Songjiao, et al.
Publicado: (2018)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer
por: Fuloria, Jyotsna
Publicado: (2012)

The inefficacy of antiangiogenic therapies
por: Ribatti, Domenico
Publicado: (2010)

Antiangiogenic Therapy for Glioma
por: Cea, Valentina, et al.
Publicado: (2012)

Antiangiogenic Cancer Therapy
por: Maxwell, P H, et al.
Publicado: (2009)

Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer
por: Ulivi, Paola, et al.
Publicado: (2016)

Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases
por: Qu, Hui, et al.
Publicado: (2023)

The semaphorins
por: Yazdani, Umar, et al.
Publicado: (2006)

Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure?
por: Willner, Nadav, et al.
Publicado: (2018)

Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression
por: Tanabe, Katsuyuki, et al.
Publicado: (2018)

Genetic Variability in L1 and L2 Genes of HPV-16 and HPV-58 in Southwest China
por: Yue, Yaofei, et al.
Publicado: (2013)

Mutational Spectrum of Semaphorin 3A and Semaphorin 3D Genes in Spanish Hirschsprung patients
por: Luzón-Toro, Berta, et al.
Publicado: (2013)

Antiangiogenic therapy for breast cancer
por: Nielsen, Dorte Lisbet, et al.
Publicado: (2010)

Antiangiogenic therapies in ovarian cancer
por: Reinthaller, Alexander
Publicado: (2016)

Antiangiogenic therapy in breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017)

Antiangiogenic Therapy for Diabetic Nephropathy
por: Tanabe, Katsuyuki, et al.
Publicado: (2017)

Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer
por: Mastrantonio, Roberta, et al.
Publicado: (2021)

Semaphorins as Potential Immune Therapeutic Targets for Cancer
por: Jiang, Jun, et al.
Publicado: (2022)

Molecular Characterization of Dengue Virus Serotype 2 Cosmospolitan Genotype From 2015 Dengue Outbreak in Yunnan, China
por: Jiang, Liming, et al.
Publicado: (2018)

Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer
por: Ramcharan, K S, et al.
Publicado: (2014)

VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
por: Varey, A H R, et al.
Publicado: (2008)

Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models
por: Qi, Ming, et al.
Publicado: (2022)

Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models
por: Qi, Ming, et al.
Publicado: (2023)

Antiangiogenic Steroids in Human Cancer Therapy
por: Pietras, Richard J., et al.
Publicado: (2005)

New perspectives in glioblastoma antiangiogenic therapy
por: Popescu, Alisa Madalina, et al.
Publicado: (2015)

The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer
por: Ikeya, Tetsuro, et al.
Publicado: (2016)

Semaphorin-3D and Semaphorin-3E Inhibit the Development of Tumors from Glioblastoma Cells Implanted in the Cortex of the Brain
por: Sabag, Adi D., et al.
Publicado: (2012)

Immunomodulation of the tumor microenvironment by neutralization of Semaphorin 4D
por: Evans, Elizabeth E, et al.
Publicado: (2015)

Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies
por: Pircher, Andreas, et al.
Publicado: (2016)

In Vitro and In Vivo Antiangiogenic Activity of Caged Polyprenylated Xanthones Isolated from Garcinia hanburyi Hook. f.
por: Yang, Jianhong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_naadqr3sg5cujmtv3r06opmtjq